Arbutus Biopharma Corp - COM (ABUS)

Historical Portfolio Holders from Q2 2015 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
96.4M
Holdings value Q2 2024
$297M
Value change Q2 2024
+$40.9M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
127
Number of buys Q2 2024
69
Number of sells Q2 2024
-39
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 73.4K $283K +$203K $3.85 3
2024 Q2 96.4M $297M +$40.9M $3.09 128
2024 Q1 83M $214M +$11.5M $2.58 118
2023 Q4 78.6M $196M +$10.9M $2.50 106
2023 Q3 70.8M $144M +$8.05M $2.03 95
2023 Q2 66.2M $152M +$7.39M $2.30 109
2023 Q1 62.4M $189M +$26.5M $3.03 120
2022 Q4 54.1M $126M +$17.8M $2.33 109
2022 Q3 46.5M $89M -$943K $1.91 118
2022 Q2 4.45K $10K -$3.05M $2.00 9
2022 Q1 43.9M $131M +$4.23M $2.98 108
2021 Q4 39.7M $154M +$14.1M $3.89 113
2021 Q3 34.9M $150M +$26.3M $4.29 95
2021 Q2 28.9M $87.6M +$7.84M $3.03 81
2021 Q1 26M $86.4M +$11.9M $3.33 86
2020 Q4 21.9M $77.7M -$4.82M $3.55 72
2020 Q3 24.1M $75.5M +$7.77M $3.13 59
2020 Q2 26.1M $47.6M +$749K $1.82 46
2020 Q1 26.3M $26.5M -$13.1M $1.01 44
2019 Q4 24.3M $67.4M +$11.9M $2.78 50
2019 Q3 19.5M $29.7M -$3.27M $1.53 43
2019 Q2 21.1M $44M -$11.2M $2.08 55
2019 Q1 24.1M $86.2M -$441K $3.58 64
2018 Q4 24.2M $92.6M -$11M $3.83 66
2018 Q3 24M $227M +$35M $9.45 87
2018 Q2 20.4M $149M +$19.4M $7.30 67
2018 Q1 18.4M $91.9M -$79.6M $5.00 46
2017 Q4 34.2M $173M +$12.8M $5.05 49
2017 Q3 32.8M $206M -$27.7M $6.20 49
2017 Q2 36.9M $133M +$3.19M $3.60 44
2017 Q1 36.3M $118M +$939K $3.25 48
2016 Q4 36.2M $88.8M +$4.2M $2.45 52
2016 Q3 33.4M $115M +$54.6M $3.44 46
2016 Q2 17.4M $60.5M -$704K $3.48 47
2016 Q1 17.5M $72.4M -$3.36M $4.13 46
2015 Q4 18.4M $81.7M -$100M $4.45 48
2015 Q3 34.9M $212M +$211M $6.09 51
2015 Q2 207K $2.46M +$2.46M $11.86 1